Asset Management One’s Alder Biopharmaceuticals ALDR Stock Holding History

Asset Management One’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-309,500	Closed	-$9.69M	–	1319
2016 Q3	$9.69M	Sell	309,500 -75,940	-20%	-$2.31M	0.14%	158
2016 Q2	$9.38M	Sell	385,440 -20,099	-5%	-$544K	0.14%	164
2016 Q1	$9.47M	Buy	405,539 +44,614	+12%	+$1.03M	0.14%	160
2015 Q4	$12.5M	Buy	360,925 +91,487	+34%	+$3.09M	0.19%	130
2015 Q3	$7.92M	Buy	269,438 +163,134	+153%	+$6.94M	0.12%	208
2015 Q2	$4.99M	Buy	+106,304	New	+$3.87M	0.07%	363

Other funds holding ALDR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

Asset Management One's ALDR Position: Q4 2016 in Review

Asset Management One sold out of Alder Biopharmaceuticals (ALDR) in Q4 2016, closing a stake of 309,500 shares — an estimated $9.69M sold.

Asset Management One first reported a position in ALDR in Q2 2015 and held it in 6 quarters. The position peaked at $12.5M in Q4 2015. 145 funds tracked by Wall St. Rank hold ALDR as of Q4 2016.

Asset Management One reported no remaining Alder Biopharmaceuticals position as of Q4 2016 after selling out during the quarter.
Asset Management One sold 309,500 Alder Biopharmaceuticals shares in Q4 2016, an estimated $9.69M.
Asset Management One first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 6 quarters.
Asset Management One's Alder Biopharmaceuticals position peaked at $12.5M in Q4 2015.
145 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2016.

Based on Asset Management One's 13F filing for Q4 2016, filed 13 Feb 2017.